FDA Inspection 1122710 — OHM Pharma, Inc.
The FDA completed an inspection of OHM Pharma, Inc. on March 18, 2020 in Mineral Wells, TX. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- March 18, 2020
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Mineral Wells, TX (United States)